Correlation Between Lixte Biotechnology and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lixte Biotechnology Holdings and Tempest Therapeutics, you can compare the effects of market volatilities on Lixte Biotechnology and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and Tempest Therapeutics.
Diversification Opportunities for Lixte Biotechnology and Tempest Therapeutics
0.39 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Lixte and Tempest is 0.39. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Lixte Biotechnology and Tempest Therapeutics
Given the investment horizon of 90 days Lixte Biotechnology Holdings is expected to generate 2.96 times more return on investment than Tempest Therapeutics. However, Lixte Biotechnology is 2.96 times more volatile than Tempest Therapeutics. It trades about 0.06 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 160.00 in Lixte Biotechnology Holdings on August 26, 2024 and sell it today you would earn a total of 3.00 from holding Lixte Biotechnology Holdings or generate 1.88% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lixte Biotechnology Holdings vs. Tempest Therapeutics
Performance |
| Timeline |
| Lixte Biotechnology |
| Tempest Therapeutics |
Lixte Biotechnology and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lixte Biotechnology and Tempest Therapeutics
The main advantage of trading using opposite Lixte Biotechnology and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Neurobo Pharmaceuticals | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd |
| Tempest Therapeutics vs. Eliem Therapeutics | Tempest Therapeutics vs. HCW Biologics | Tempest Therapeutics vs. Scpharmaceuticals | Tempest Therapeutics vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |